Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
ID: 350883Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity for Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases under the R01 grant mechanism, which does not allow clinical trials. This initiative aims to support research projects that collect critical data to inform future clinical trials and observational studies, focusing on non-interventional studies that assess disease symptoms, progression, and patient outcomes. The funding, capped at $475,000 over a maximum of four years, is open to a diverse range of applicants, including higher education institutions and nonprofit organizations, with application submissions starting on February 4, 2024, and continuing through late 2026. For further details, applicants can reach out to NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-036.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has issued a Notice of Funding Opportunity (NOFO), PAR-24-036, targeting Clinical Observational (CO) Studies in musculoskeletal, rheumatic, and skin diseases. The primary aim of this initiative is to secure applications for Research Project Grants (R01) that will collect data to design future clinical trials and observational studies. The emphasis is on non-interventional studies that gather information on disease symptoms, progression stages, and patient outcomes vital for future clinical research. Eligible applicants include higher education institutions, nonprofits, and various levels of government. Funding is capped at $475,000 over a maximum four-year project period, with stringent adherence to submission requirements highlighted. Key deadlines include submission openings on February 4, 2024, with multiple application cycles running through late 2026. The review process emphasizes the significance, innovation, and overall impact of proposed studies, requiring emphasis on diversity among participant demographics. The NOFO encourages the incorporation of telehealth, digital outcomes, and wearable devices in observational studies, ultimately striving to enhance clinical research around chronic diseases impacting largely diverse populations.
    Similar Opportunities
    Loading similar opportunities...